AMH protects the ovary from doxorubicin by regulating cell fate and the response to DNA damage
Authors:
- Ngoc Minh Phuong NguyenNNNgoc Minh Phuong Nguyen
- Eun Mi ChangECEun Mi Chang
- Maeva ChauvinMCMaeva Chauvin
- Natalie SicherNSNatalie Sicher
- Aki KashiwagiAKAki Kashiwagi
- Christina ChowCCChristina Chow
- Alana Mermin-BunnellAMAlana Mermin-Bunnell
- Josephine CleverdonJCJosephine Cleverdon
- Motohiro KanoMKMotohiro Kano
Open Access
- 28 January 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (5)
Abstract
Anti-Müllerian hormone (AMH) protects the ovarian reserve from chemotherapy, and this effect is most pronounced with Doxorubicin (DOX). However, DOX toxicity and AMH rescue mechanisms in the ovary have remained unclear. Herein, we characterize the consequences of these treatments in ovarian cell types using scRNAseq. DOX-induced DNA damage activates Tp53 class mediators across ovarian cell types. In the mesenchyme, cotreatment with AMH halts theca progenitor differentiation and reduces apoptotic gene expression. In preantral granulosa cells, DOX upregulates the cell cycle inhibitor Cdkn1a and dysregulates Wnt signaling, which are ameliorated by AMH cotreatment. Finally, AMH induces Id3 , a gene involved in DNA repair, which is necessary to prevent the accumulation of DNA lesions marked by γ-H2AX. Altogether these mechanisms of AMH protection contribute to sustained fertility in mice, offering promising broad avenues for fertility preservation in cancer patients undergoing chemotherapy.Keywords
All Related Versions
Funding Information
- HHS | NIH | NICHD | Reproductive Scientist Development Program (1R01HD102014)
This publication has 60 references indexed in Scilit:
- Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolyticsGeroScience, 2023
- A molecular atlas of the human postmenopausal fallopian tube and ovary from single-cell RNA and ATAC sequencingCell Reports, 2022
- AMH inhibits androgen production in human theca cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2022
- Anti-Müllerian hormone inhibits luteinizing hormone-induced androstenedione synthesis in porcine theca cellsTheriogenology, 2020
- Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effectsJournal of Assisted Reproduction and Genetics, 2019
- Integrating single-cell transcriptomic data across different conditions, technologies, and speciesNature Biotechnology, 2018
- Identification of Senescent Cells in the Bone MicroenvironmentJournal of Bone and Mineral Research, 2016
- Ovarian theca cells in follicular functionReproductive BioMedicine Online, 2007
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993
- Isolation of the bovine and human genes for müllerian inhibiting substance and expression of the human gene in animal cellsCell, 1986